These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35552214)

  • 1. Budesonide bests COVID-19.
    Moe SS; Allan GM; Train A
    Can Fam Physician; 2022 May; 68(5):355. PubMed ID: 35552214
    [No Abstract]   [Full Text] [Related]  

  • 2. [Not Available].
    Steurer J
    Praxis (Bern 1994); 2021 Aug; 110(10):595-596. PubMed ID: 34344196
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhaled Budesonide Reduces the Risk of Emergency Department Evaluation or Hospitalization in Early COVID-19.
    Ebell MH
    Am Fam Physician; 2021 Aug; 104(2):207-208. PubMed ID: 34383442
    [No Abstract]   [Full Text] [Related]  

  • 4. Is inhaled budesonide an effective treatment for patients with mild early symptoms of COVID-19?
    Kareemi H; Rosenberg H; Yadav K
    CJEM; 2021 Sep; 23(5):611-612. PubMed ID: 34279822
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inhaled budesonide in the treatment of COVID-19].
    Kluge S; Nitschmann S; Scherer M
    Internist (Berl); 2021 Aug; 62(8):887-889. PubMed ID: 34191054
    [No Abstract]   [Full Text] [Related]  

  • 6. High-dose budesonide for early COVID-19.
    Berezowski I; Patel J; Shaw M; Pourmand A
    Lancet; 2021 Dec; 398(10317):2146-2147. PubMed ID: 34895527
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhaled budesonide for early treatment of COVID-19.
    San-Juan R; Fernández-Ruiz M; López-Medrano F; Aguado JM
    Lancet Respir Med; 2021 Jul; 9(7):e58. PubMed ID: 33991508
    [No Abstract]   [Full Text] [Related]  

  • 8. High-dose budesonide for early COVID-19.
    Lipworth B; Chan R; Misirovs R
    Lancet; 2021 Dec; 398(10317):2147. PubMed ID: 34895529
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhaled budesonide for early treatment of COVID-19.
    Choi JC; Kim WY
    Lancet Respir Med; 2021 Jul; 9(7):e60. PubMed ID: 33991507
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhaled budesonide for early treatment of COVID-19.
    Zeitlinger M; Idzko M
    Lancet Respir Med; 2021 Jul; 9(7):e59. PubMed ID: 33991506
    [No Abstract]   [Full Text] [Related]  

  • 11. Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial.
    Agustí A; De Stefano G; Levi A; Muñoz X; Romero-Mesones C; Sibila O; Lopez-Giraldo A; Plaza Moral V; Curto E; Echazarreta AL; Márquez SE; Pascual-Guàrdia S; Santos S; Marin A; Valdés L; Saldarini F; Salgado C; Casanovas G; Varea S; Ríos J; Faner R
    Eur Respir J; 2022 Mar; 59(3):. PubMed ID: 35144989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19.
    Agusti A; Torres F; Faner R
    Lancet Respir Med; 2021 Jul; 9(7):682-683. PubMed ID: 33844998
    [No Abstract]   [Full Text] [Related]  

  • 13. [Not Available].
    Reinhardt D
    MMW Fortschr Med; 2021 Apr; 163(8):27-28. PubMed ID: 33904080
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhaled budesonide for mild COVID-19. Is there more to it than just airways?
    Rathi S; Ish P; Kalantri A; Kalantri S
    Adv Respir Med; 2021; 89(5):552-553. PubMed ID: 34668186
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiviral Effect of Budesonide against SARS-CoV-2.
    Heinen N; Meister TL; Klöhn M; Steinmann E; Todt D; Pfaender S
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis.
    Baker JR; Mahdi M; Nicolau DV; Ramakrishnan S; Barnes PJ; Simpson JL; Cass SP; Russell REK; Donnelly LE; Bafadhel M
    Lancet Respir Med; 2022 Jun; 10(6):545-556. PubMed ID: 35397798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential therapeutic role of budesonide to reduce COVID-19 severity.
    Mohiuddin M; Kasahara K
    J Infect Public Health; 2022 Jan; 15(1):109-111. PubMed ID: 34802976
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose budesonide for early COVID-19 - Authors' reply.
    Hobbs FDR; Yu LM; Saville BR; Bafadhel M; Butler CC
    Lancet; 2021 Dec; 398(10317):2147-2148. PubMed ID: 34895528
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhaled budesonide for early treatment of COVID-19 - Authors' reply.
    Ramakrishnan S; Bafadhel M
    Lancet Respir Med; 2021 Jul; 9(7):e61. PubMed ID: 33991509
    [No Abstract]   [Full Text] [Related]  

  • 20. [The treatment of acute laryngitis with budesonide].
    Kong X; Bao X; Zhang Y
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Dec; 49(12):1038-9. PubMed ID: 25623878
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.